Several cytostatic drugs and cyclooxygenase 2 (COX-2) inhibitors appear to prolong survival times in TCC patients [8,9], whereas few studies support slight effects of COX-2 inhibitors solely or combined with chemotherapeutic agents against canine PAC [10,11]. Here, PTGS2 is linked to gonorrhea.